Delivery Order SPE2DR25D1104-SPE2DR26FL242
Award Date 2/17/26
Potential Completion Date 2/18/26
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $2,598.15 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for CellCept 500 mg tablets (100s).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 11, 2026, and is priced on a firm fixed-price basis with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $24,389.78 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for CellCept 500 mg tablets (100 count), with an ultimate completion date of February 11, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was awarded on a firm fixed-price basis with no set-aside.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,236.08 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) with a firm fixed price contract type. The award was made on November 18, 2025, with an ultimate completion date of November 19, 2025, and the product will be performed from the contractor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $19,770.34. This firm fixed price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of CellCept 500 mg tablets (100 count) with a contract value of $3,302.10 and an ultimate completion date of January 6, 2026. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a competitively awarded transaction under AmerisourceBergen Drug Corp's larger federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count units) valued at $14,887.62 under a firm fixed-price contract. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate Office location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,909.55 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a delivery order valued at $33,203.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (500-count units). This competitive, firm fixed-price delivery order was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract does not carry a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count units) valued at $10,230.62 under a firm fixed-price contract awarded on October 28, 2025, with an ultimate completion date of October 29, 2025. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FL242Delivery Order
The Defense Logistics Agency issued a $36,168.72 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for CellCept 500 mg tablets (100-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical commodities to military healthcare programs worldwide. Place of performance is Conshohocken, PA. The ultimate completion date is February 18, 2026. Pricing is firm fixed price. The order was competitively awarded with no set-aside.
Generated 5/18/26, 9:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.2k | 2/16/26 |